(The following information was provided by the Almac Group.)
Almac Group, the global contract development and manufacturing organization, recently marked the ceremonial ground breaking of a $65 million expansion project on the company’s North American headquarters campus in Lower Salford.
This expansion is a strategic investment in cold chain operations, just-in-time processing, and analytical testing capabilities crucial to supporting the development of Advanced Therapeutic Medicinal Products (ATMPs). As previously announced in August 2022, the expansion will yield a 60% increase in capacity for Almac’s clients, supported with a projected total of 355 new jobs by 2026.
The project will bring 115,000ft2 of new building space to the campus, adding an additional 50% of the current footprint upon its completion in 2025. In keeping with Almac’s commitment to reach net-zero emissions by 2045, construction plans will follow U.S. Green Building Council LEED certification standards for healthy, efficient, carbon and cost-saving green buildings.
Further environmental safeguards include the installation of a 140-foot pedestrian bridge to minimize impact to the environment on the expanded campus, while also enhancing walkability for employees and guests.
This news follows Almac’s recent announcement of record breaking financial results and confirmation that its global workforce has reached 7,000.
“Today’s ceremony is a welcome sign of the continuation of growth for the Almac Group,” said Alan Armstrong, Almac Group Chairman and CEO, at the groundbreaking ceremony. “I would like to thank all within the organisation for playing their part in our success. We are committed to reinvesting all our profits back into the business, and this expansion in Pennsylvania will play a vital part in our continued growth.”
“Almac is dedicated to ensuring we remain a global leader in our industry, giving our clients, and ultimately patients, across the world the best possible offering,” Armstrong continued. “We continue to play our part as a valued and trusted member of the communities in which we operate.”
About Almac Group
The Almac Group is an established contract development and manufacturing organisation providing an extensive range of integrated services across the drug development lifecycle to the pharmaceutical and biotech sectors globally. Its innovative services range from R&D, biomarker discovery development and commercialisation, API manufacture, analytical services, formulation development, clinical trial supply, IRT (IVRS/IWRS) through to commercial-scale manufacture.
The international company is a privately owned organisation which has grown organically over the past five decades now employing over 7,000 highly skilled personnel across 18 facilities including Europe, the USA and Asia.
See also:
Historic Sellersville Factory To Be Reborn As Loft Apartments
Total Liquidators Aims For August Opening In Towamencin
Colmar Cheesesteaks & Wings Opens At Former Colmar Inn Location
Briteway Express Car Wash Holds Grand Opening in Telford
Sellersville Native Launches Junk Removal Company
